SIGA TECHNOLOGIES INC

SIGA Technologies Inc.

Drug Manufacturers - Specialty & Generic Healthcare New York, NY, United States SIGA (NGM)

SIGA Technologies, Inc., a commercial-stage pharmaceutical company, focuses on the health security market in the United States. Its lead product is TPOXX, an antiviral drug for the treatment of human smallpox disease caused by variola virus. The company was incorporated in 1995 and is headquartered in New York, New York.

Stock Performance (90 Days)

Data through Dec 29, 2025
Price updates on page refresh. Intraday quotes available during market hours (9:30 AM - 4:00 PM EST).

Layoff History

No layoff events recorded for this company.

Recent News

Other Drug Manufacturers - Specialty & Generic Companies

View All →

Frequently Asked Questions

Has SIGA TECHNOLOGIES INC had layoffs?
No layoff events have been recorded for SIGA TECHNOLOGIES INC in our database. This could mean the company has not conducted significant layoffs, or any layoffs have not been publicly reported.
How many employees does SIGA TECHNOLOGIES INC have?
SIGA TECHNOLOGIES INC has approximately 46 employees.
What industry is SIGA TECHNOLOGIES INC in?
SIGA TECHNOLOGIES INC operates in the Drug Manufacturers - Specialty & Generic industry, within the Healthcare sector.
Is SIGA TECHNOLOGIES INC a publicly traded company?
Yes, SIGA TECHNOLOGIES INC is publicly traded under the ticker symbol SIGA on the NGM. The company has a market capitalization of approximately $0.45 billion.
Where is SIGA TECHNOLOGIES INC headquartered?
SIGA TECHNOLOGIES INC is headquartered in New York, NY, United States at 31 East 62nd Street, New York, NY 10065, United States.

Disclaimer

Data aggregated from public sources including WARN notices, SEC filings, press releases, and market data. While we strive for accuracy, information is provided "as-is" for informational purposes only. Always verify critical information with official company sources.

This information does not constitute investment, financial, legal, or career advice. See our Terms of Service, Privacy Policy, and About page for more information.

Found an error? Report it here.